FDA Warns of Counterfeit Version Of Teva’s ADHD, Narcolepsy Drug Adderall

May 30, 2012, 9:58 PM UTC

The Food and Drug Administration May 29 warned consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries Ltd.'s Adderall 30 milligram tablets that is being purchased on the internet.

Adderall, which is approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, is a prescription drug classified as a controlled substance—a class of drug for which special controls are required for dispensing by pharmacists, the agency said. FDA’s preliminary laboratory tests revealed that the counterfeit version of Adderall 30 mg tablets contains the wrong active ingredients.

The agency said Adderall contains four active ingredients: dextroamphetamine saccharate, ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.